Why it was included in the FDA ban The FDA cites significant safety risks due to the potential for congestive heart failure in certain patients seen in a clinical trial that was terminated
This gradual increase in dosage helps users adjust and minimise the gastrointestinal side effects during the early treatment period
SURMOUNT-1 results at 72 weeks This landmark trial published in the New England Journal of Medicine enrolled 2,539 adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related complication
The hypothalamic-pituitary-gonadal (HPG) axis is suppressed by excess adiposity, elevated estrogen, insulin resistance, and chronic inflammation all of which improve when body fat decreases
Although it is a good source of fibre and helps feed gut bugs, it ferments within the gut and can cause a lot of gut issues like extreme gas, cramping and bloating
Specific vendor reviews for retatrutide, such as the Paradigm Peptides retatrutide review , provide compound-specific sourcing insights